Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group (Q48615081)
Jump to navigation
Jump to search
scientific article published on 13 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group |
scientific article published on 13 March 2012 |
Statements
1 reference
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group (English)
1 reference
Giannis Mountzios
1 reference
Christos Emmanouilidis
1 reference
Nikolaos Vardakis
1 reference
Emmanouil Kontopodis
1 reference
Dora Hatzidaki
1 reference
Evagelos Popis
1 reference
Niki Karachaliou
1 reference
Athanassios Kotsakis
1 reference
Maria Agelidou
1 reference
Vassilis Georgoulias
1 reference
13 March 2012
1 reference
1 reference
77
1 reference
1
1 reference
146-150
1 reference
Identifiers
1 reference